Display options
Cite
Cerezo C, Segura J, Praga M, et al. Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension. Curr Hypertens Rep. 2013;15(3):196-203doi: 10.1007/s11906-013-0337-4.
Cerezo, C., Segura, J., Praga, M., & Ruilope, L. M. (2013). Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension. Current hypertension reports, 15(3), 196-203. https://doi.org/10.1007/s11906-013-0337-4
Cerezo, César, et al. "Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension." Current hypertension reports vol. 15,3 (2013): 196-203. doi: https://doi.org/10.1007/s11906-013-0337-4
Cerezo C, Segura J, Praga M, Ruilope LM. Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension. Curr Hypertens Rep. 2013 Jun;15(3):196-203. doi: 10.1007/s11906-013-0337-4. PMID: 23519746.
Copy Download .nbib Format: NLM
Share it on

Curr Hypertens Rep. 2013 Jun;15(3):196-203. doi: 10.1007/s11906-013-0337-4.

Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension.

Current hypertension reports

César Cerezo, Julian Segura, Manuel Praga, Luis M Ruilope

Affiliations

  1. Hypertension Unit, Nephrology Department, Hospital 12 de Octubre Av. Córdoba s/n, 28041, Madrid, Spain. [email protected]

PMID: 23519746 DOI: 10.1007/s11906-013-0337-4

Abstract

Obesity and overweight are nowadays very prevalent worldwide. They are known to be linked with an increased risk of developing cardiovascular comorbidities and mortality. Abdominal obesity is frequently associated with a collection of metabolic disorders that include elevated blood pressure, characteristic lipid abnormalities (low high-density lipoprotein cholesterol and high triglycerides) and increased fasting glucose, with an underlying situation of insulin resistance, which has been defined as metabolic syndrome, conferring a high cardiovascular risk profile to these subjects. A multidisciplinary approach is required, including lifestyle changes and pharmacological and surgical approaches. Intensive management of all the risk factors of the metabolic syndrome is also needed to reduce body weight and waist circumference, lessen insulin resistance and avoid the development of new-onset diabetes and cardiovascular disease associated with this entity. This article will review the recently published literature and guideline updates on this topic, although it is not yet included in the highlights.

References

  1. Circulation. 2002 Dec 17;106(25):3143-421 - PubMed
  2. JAMA. 2001 Mar 21;285(11):1447-54 - PubMed
  3. Obesity (Silver Spring). 2012 Feb;20(2):330-42 - PubMed
  4. J Hypertens. 2009 Nov;27(11):2121-58 - PubMed
  5. Circulation. 2005 Aug 2;112(5):666-73 - PubMed
  6. NCHS Data Brief. 2012 Jan;(82):1-8 - PubMed
  7. Blood Press. 2007;16(3):135-232 - PubMed
  8. Hypertension. 2007 Jan;49(1):40-7 - PubMed
  9. Diabetes Care. 1991 Dec;14(12):1132-43 - PubMed
  10. JAMA. 2013 Jan 2;309(1):71-82 - PubMed
  11. N Engl J Med. 2006 Oct 12;355(15):1551-62 - PubMed
  12. Circulation. 2012 Sep 4;126(10):1301-13 - PubMed
  13. Lancet. 2007 Jan 20;369(9557):201-7 - PubMed
  14. Eur Heart J. 2013 Feb;34(5):345-53 - PubMed
  15. BMJ. 2012 Jun 26;344:e4026 - PubMed
  16. Eur Heart J. 2006 Jan;27(1):96-106 - PubMed
  17. J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32 - PubMed
  18. J Intern Med. 2000 Sep;248(3):245-54 - PubMed
  19. Lancet. 2005 Sep 24-30;366(9491):1059-62 - PubMed
  20. Diabet Med. 1999 May;16(5):442-3 - PubMed
  21. J Am Coll Cardiol. 2012 Feb 14;59(7):635-43 - PubMed
  22. Am J Clin Nutr. 2010 Jan;91(1):7-15 - PubMed
  23. J Clin Endocrinol Metab. 2011 Oct;96(10):3067-77 - PubMed
  24. Arteriosclerosis. 1990 Jul-Aug;10(4):497-511 - PubMed
  25. Obesity (Silver Spring). 2006 Feb;14 Suppl 1:16S-19S - PubMed
  26. J Hypertens. 2007 Jun;25(6):1105-87 - PubMed
  27. J Clin Endocrinol Metab. 2012 Jun;97(6):2151-9 - PubMed
  28. Circulation. 2009 Oct 20;120(16):1640-5 - PubMed
  29. Diabetes Care. 2004 Nov;27(11):2676-81 - PubMed
  30. Obes Rev. 2012 Apr;13(4):388-92 - PubMed
  31. JAMA. 2012 Jan 4;307(1):56-65 - PubMed
  32. Hypertension. 2009 Apr;53(4):577-84 - PubMed
  33. J Hypertens. 2006 Jul;24(7):1405-12 - PubMed
  34. Diabetes Care. 2007 Mar;30(3):753-9 - PubMed
  35. Lancet. 2009 Nov 7;374(9701):1606-16 - PubMed
  36. Am J Clin Nutr. 2006 Jun;83(6):1237-47 - PubMed
  37. Circulation. 2011 Dec 6;124(23):2483-90 - PubMed
  38. Ann N Y Acad Sci. 2010 Nov;1212:E1-E19 - PubMed
  39. JAMA. 2001 May 16;285(19):2486-97 - PubMed
  40. Am J Clin Nutr. 2010 Mar;91(3):547-56 - PubMed
  41. Clin Endocrinol (Oxf). 2003 May;58(5):562-71 - PubMed
  42. Obes Res. 1998 Sep;6 Suppl 2:51S-209S - PubMed
  43. Ann Intern Med. 1989 Nov 15;111(10):783-7 - PubMed
  44. N Engl J Med. 2012 Apr 26;366(17):1567-76 - PubMed
  45. Circulation. 2005 Oct 25;112(17):2735-52 - PubMed
  46. Circulation. 2011 Dec 13;124(24):e837-41 - PubMed
  47. Prev Med. 2008 Oct;47(4):389-93 - PubMed
  48. Eur J Heart Fail. 2012 Aug;14(8):909-15 - PubMed
  49. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 - PubMed
  50. N Engl J Med. 2008 Dec 4;359(23):2417-28 - PubMed
  51. Ann Intern Med. 2010 Aug 3;153(3):147-57 - PubMed
  52. Int J Obes (Lond). 2007 Apr;31(4):692-9 - PubMed

MeSH terms

Publication Types